Alyeska Investment Group, L.P. Kymera Therapeutics, Inc. Transaction History

Alyeska Investment Group, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$14.13 - $42.55 $2.6 Million - $7.82 Million	-183,750 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$35.3 - $64.68 $2.03 Million - $3.72 Million	57,457 Added 45.49%	183,750 $7.78 Million
Q4 2021 Feb 14, 2022	BUY	$49.91 - $65.56 $64,533 - $84,769	1,293 Added 1.03%	126,293 $8.02 Million
Q3 2021 Nov 15, 2021	BUY	$47.8 - $66.66 $5.98 Million - $8.33 Million	125,000 New	125,000 $7.34 Million

183

64.4M

50.6K

81.7K

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.09B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.